Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-05-006534
Filing Date
2005-03-15
Accepted
2005-03-15 16:16:41
Documents
10
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2149545z10-k.htm 10-K 853475
2 EXHIBIT 10.15 a2149545zex-10_15.htm EX-10.15 4255
3 EXHIBIT 10.16 a2149545zex-10_16.htm EX-10.16 36004
4 EXHIBIT 10.17 a2149545zex-10_17.htm EX-10.17 31525
5 EXHIBIT 21.1 a2149545zex-21_1.htm EX-21.1 3642
6 EXHIBIT 23.1 a2149545zex-23_1.htm EX-23.1 2182
7 EXHIBIT 31.1 a2149545zex-31_1.htm EX-31.1 6176
8 EXHIBIT 31.2 a2149545zex-31_2.htm EX-31.2 6229
9 EXHIBIT 32.1 a2149545zex-32_1.htm EX-32.1 3135
10 EXHIBIT 32.2 a2149545zex-32_2.htm EX-32.2 3178
  Complete submission text file 0001047469-05-006534.txt   952385
Mailing Address 311 BONNIE CIRCLE CORONA CA 92880
Business Address 311 BONNIE CIRCLE CORONA CA 92880 9092701400
WATSON PHARMACEUTICALS INC (Filer) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13305 | Film No.: 05681912
SIC: 2834 Pharmaceutical Preparations